These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 8962724
1. [A quantitative study of the presence of interleukin-1 and interleukin-6 in cholesteatoma of the middle ear]. Aumente PO, Bujía J, Kim C, Jiménez Giménez J, López Villarejo P. Acta Otorrinolaringol Esp; 1996; 47(4):259-62. PubMed ID: 8962724 [Abstract] [Full Text] [Related]
2. [Interleukin-1-containing cells in cholesteatoma of the middle ear]. Schilling V, Bujia J, Negri B, Kastenbauer E. Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549 [Abstract] [Full Text] [Related]
3. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Schilling V, Negri B, Bujía J, Schulz P, Kastenbauer E. Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343 [Abstract] [Full Text] [Related]
4. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Bujía J, Kim C, Ostos P, Kastenbauer E, Hültner L. Eur Arch Otorhinolaryngol; 1996 Jul; 253(3):152-7. PubMed ID: 8652157 [Abstract] [Full Text] [Related]
5. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Bujía J, Kim C, Holly A, Sudhoff H, Ostos P, Kastenbauer E. Am J Otol; 1996 Mar; 17(2):203-6. PubMed ID: 8723947 [Abstract] [Full Text] [Related]
6. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma]. Liu J, Lin G, Huang J, Jiang Z. Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791 [Abstract] [Full Text] [Related]
7. Functional characterization of middle ear mucosa residues in cholesteatoma samples. Sudhoff H, Bujía J, Holly A, Kim C, Fisseler-Eckhoff A. Am J Otol; 1994 Mar; 15(2):217-21. PubMed ID: 8172304 [Abstract] [Full Text] [Related]
8. Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Bujía J, Kim C, Ostos P, Sudhoff H, Kastenbauer E, Hültner L. Eur Arch Otorhinolaryngol; 1996 Mar; 253(4-5):252-5. PubMed ID: 8737779 [Abstract] [Full Text] [Related]
9. [Angiogenesis in cholesteatoma of the middle ear]. Bujía J, Holly A, Stammberger M, Sudhoff H. Acta Otorrinolaringol Esp; 1996 Mar; 47(3):187-92. PubMed ID: 8924281 [Abstract] [Full Text] [Related]
14. Effect of endotoxin on cultured rat middle ear epithelium, rat meatal epidermis, and human keratinocytes. Hesseling SC, van Blitterswijk CA, Lim DJ, DeMaria TF, Bakaletz LO, Grote JJ. Am J Otol; 1994 Nov; 15(6):762-8. PubMed ID: 8572089 [Abstract] [Full Text] [Related]
16. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation]. Bujía J, Holly A, Kim C, Schilling V, Kastenbauer E. Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881 [Abstract] [Full Text] [Related]
17. Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma. Ahn JM, Huang CC, Abramson M. Otolaryngol Head Neck Surg; 1990 Oct; 103(4):527-36. PubMed ID: 2174138 [Abstract] [Full Text] [Related]